This brand name is authorized in Austria, Brazil, Canada, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Turkey, United Kingdom, United States
The drug TAKHZYRO contains one active pharmaceutical ingredient (API):
|
1
Lanadelumab
UNII 2372V1TKXK - LANADELUMAB
|
|
Lanadelumab is a fully human, monoclonal antibody (IgG1/κ-light chain). Lanadelumab inhibits active plasma kallikrein proteolytic activity. Lanadelumab provides sustained control of plasma kallikrein activity and thereby limits bradykinin generation in patients with HAE. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| TAKHZYRO Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B06AC05 | B Blood and blood forming organs → B06 Other hematological agents → B06A Other hematological agents → B06AC Drugs used in hereditary angioedema | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 501121030038917 |
| Country: CA | Health Products and Food Branch | Identifier(s): 02480948, 02505614 |
| Country: EE | Ravimiamet | Identifier(s): 1783144, 1814037, 1814048, 1827367 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 1181340004 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 122129 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 61988861, 63473155 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 377339, 395164 |
| Country: HK | Department of Health Drug Office | Identifier(s): 67123 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 89097 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 9116 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 047417011, 047417023, 047417035, 047417047, 047417050, 047417062, 047417074, 047417086, 047417098 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 4490407G1023 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1086746, 1089620, 1089621, 1091775, 1091776, 1091777 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 16890698 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 201618 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 20817 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100416826 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W68151001 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8681429550530, 8681429550547, 8681429550554 |
| Country: US | FDA, National Drug Code | Identifier(s): 47783-644 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
